US03763A2078
US03763A2078
Astrana Health Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.86B EUR | 2.28B EUR | 1.2B EUR | 1.21B EUR |
Enterprise Value | 2.18B EUR | 2.86B EUR | 1.79B EUR | 1.86B EUR |
Valuation Multiples | ||||
Trailing P/E | 45.24x | 56.35x | 39.7x | 76.79x |
Forward P/E | 10.33x | -- | -- | -- |
Price to Sales | 0.48x | 0.59x | 0.34x | 0.47x |
Price to Book | 2.23x | 2.75x | 1.5x | 1.56x |
EV/Revenue | 0.57x | 0.74x | 0.51x | 0.73x |
EV/EBITDA | 12.48x | 15.5x | 11.05x | 16.69x |
Price to FCF (P/FCF) | 8.06x | 24.21x | 7.74x | 13.34x |
EV/FCF | 9.44x | 30.34x | 11.53x | 20.47x |
FCF Yield | 12.41% | 4.13% | 12.91% | 7.5% |